SC: Magistrates Should Not Record Prosecution Evidence in Sessions-Triable Cases || Supreme Court Lays Down Guidelines on Using ITRs to Assess Motor Accident Victims' Income || Supreme Court: Citing AI-Generated Fake Precedents Amounts to Advocate Misconduct || Bombay HC: Horse-Trading Rampant in Maharashtra, FIRs 'Washed' After Switching Sides || Tripura High Court: Senior Citizens Cannot be Penalised For Failing to Follow Cases Online || Delhi High Court: Parent Cannot Gain Advantage by Keeping a Child Against a Foreign Court Order || Allahabad HC: Places of Worship Act Bars Conversion of Religious Character, Not State Acquisition || Jharkhand HC: Single Instance of Mother-In-Law Abusing Daughter-In-Law Does Not Amount to Cruelty || Madras High Court: No Appeal Lies Against E-Court Status or Adjournment Orders || Chhattisgarh HC: Judicial Officer Promotion Cannot be Denied on Complaint Without Disciplinary Action

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :